166 related articles for article (PubMed ID: 956401)
1. Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man.
Felig P; Wahren J; Hendler R
J Clin Invest; 1976 Sep; 58(3):761-5. PubMed ID: 956401
[TBL] [Abstract][Full Text] [Related]
2. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
3. Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.
Sherwin RS; Bastl C; Finkelstein FO; Fisher M; Black H; Hendler R; Felig P
J Clin Invest; 1976 Mar; 57(3):722-31. PubMed ID: 1249205
[TBL] [Abstract][Full Text] [Related]
4. Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man.
Liljenquist JE; Mueller GL; Cherrington AD; Keller U; Chiasson J-L ; Perry JM; Lacy WW; Rabinowitz D
J Clin Invest; 1977 Feb; 59(2):369-74. PubMed ID: 833282
[TBL] [Abstract][Full Text] [Related]
5. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man.
Saccà L; Cicala M; Trimarco B; Ungaro B; Vigorito C
J Clin Invest; 1982 Jul; 70(1):117-26. PubMed ID: 6123524
[TBL] [Abstract][Full Text] [Related]
7. The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog.
Cherrington AD; Chiasson JL; Liljenquist JE; Jennings AS; Keller U; Lacy WW
J Clin Invest; 1976 Dec; 58(6):1407-18. PubMed ID: 993351
[TBL] [Abstract][Full Text] [Related]
8. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
Raskin P; Fujita Y; Unger RH
J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
[TBL] [Abstract][Full Text] [Related]
9. Epinephrine-induced insulin resistance in man.
Deibert DC; DeFronzo RA
J Clin Invest; 1980 Mar; 65(3):717-21. PubMed ID: 6243677
[TBL] [Abstract][Full Text] [Related]
10. Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man.
Dirlewanger M; Schneiter PH; Paquot N; Jequier E; Rey V; Tappy L
Clin Nutr; 2000 Feb; 19(1):29-34. PubMed ID: 10700531
[TBL] [Abstract][Full Text] [Related]
11. Differential roles of splanchnic and peripheral tissues in the pathogenesis of impaired glucose tolerance.
Saccà L; Orofino G; Petrone A; Vigorito C
J Clin Invest; 1984 Jun; 73(6):1683-7. PubMed ID: 6373828
[TBL] [Abstract][Full Text] [Related]
12. Splanchnic and leg exchange of glucose, amino acids, and free fatty acids during exercise in diabetes mellitus.
Wahren J; Hagenfeldt L; Felig P
J Clin Invest; 1975 Jun; 55(6):1303-14. PubMed ID: 1133176
[TBL] [Abstract][Full Text] [Related]
13. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
Bjorkman O; Miles P; Wasserman D; Lickley L; Vranic M
J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
[TBL] [Abstract][Full Text] [Related]
14. Effect of glucagon on net splanchnic cyclic AMP production in normal and diabetic men.
Liljenquist JE; Bomboy JD; Lewis SB; Sinclair-Smith BC; Felts PW; Lacy WW; Crofford OB; Liddle GW
J Clin Invest; 1974 Jan; 53(1):198-204. PubMed ID: 4357612
[TBL] [Abstract][Full Text] [Related]
15. Role of basal glucagon levels in the regulation of splanchnic glucose output and ketogenesis in insulin-deficient humans.
Björkman O; Felig P; Wahren J
Clin Physiol; 1984 Jun; 4(3):227-41. PubMed ID: 6146427
[TBL] [Abstract][Full Text] [Related]
16. Insulin-glucagon interaction in controlling splanchnic glucose production in normal man.
Bomboy JD; Lewis SB; Sinclair-Smith BC; Lacy WW; Liljenquist JE
J Clin Endocrinol Metab; 1977 Mar; 44(3):474-80. PubMed ID: 838848
[TBL] [Abstract][Full Text] [Related]
17. Transient stimulatory effect of sustained hyperglucagonemia on splanchnic glucose production in normal and diabetic man.
Bomboy JD; Lewis SB; Lacy WW; Sinclair-Smith BC; Liljenquist JE
Diabetes; 1977 Mar; 26(3):177-4. PubMed ID: 190074
[TBL] [Abstract][Full Text] [Related]
18. Effect of verapamil on basal and glucagon-dependent splanchnic glucose metabolism and insulin secretion in man.
Gasić S; Bratusch-Marrain P; Waldhäusl W; Korn A
Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):36-40. PubMed ID: 3042640
[TBL] [Abstract][Full Text] [Related]
19. Role of the splanchnic tissues in the pathogenesis of altered carbohydrate metabolism in patients with chronic renal failure.
Capaldo B; Cianciaruso B; Napoli R; Andreucci V; Kopple JD; Saccà L
J Clin Endocrinol Metab; 1990 Jan; 70(1):127-33. PubMed ID: 2403570
[TBL] [Abstract][Full Text] [Related]
20. Role of cyclic AMP in glucagon-induced stimulation of hepatic glucose output in man.
Grill V; Cerasi E; Wahren J
Scand J Clin Lab Invest; 1979 Dec; 39(8):689-96. PubMed ID: 231294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
